Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

DAT

  • You have access
    Functional Imaging of Chemobrain: Usefulness of Nuclear Medicine in the Fog Coming After Cancer
    Agostino Chiaravalloti, Luca Filippi, Marco Pagani and Orazio Schillaci
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 508-514; DOI: https://doi.org/10.2967/jnumed.121.263294
  • You have access
    Whole-Body Biodistribution and Dosimetry of the Dopamine Transporter Radioligand 18F-FE-PE2I in Human Subjects
    Helena Lizana, Lennart Johansson, Jan Axelsson, Anne Larsson, Mattias Ögren, Jan Linder, Christer Halldin, Andrea Varrone and Susanna Jakobson Mo
    Journal of Nuclear Medicine August 1, 2018, 59 (8) 1275-1280; DOI: https://doi.org/10.2967/jnumed.117.197186
  • You have access
    Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases
    Merijn Joling, Chris Vriend, Odile A. van den Heuvel, Pieter G.H.M. Raijmakers, Paul A. Jones, Henk W. Berendse and Jan Booij
    Journal of Nuclear Medicine July 1, 2017, 58 (7) 1117-1123; DOI: https://doi.org/10.2967/jnumed.116.182139
  • You have access
    Use of 11C-PE2I PET in Differential Diagnosis of Parkinsonian Disorders
    Lieuwe Appel, My Jonasson, Torsten Danfors, Dag Nyholm, Håkan Askmark, Mark Lubberink and Jens Sörensen
    Journal of Nuclear Medicine February 1, 2015, 56 (2) 234-242; DOI: https://doi.org/10.2967/jnumed.114.148619
SNMMI

© 2025 SNMMI

Powered by HighWire